Keiichiro Uehara

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study

Shunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto et al. · Journal of Thoracic Oncology · 2017 · 368 citations · Full text

Oncology, Cancer Epidemiology, Cancer Management +9

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

Daichi Fujimoto, Keiichiro Uehara, Yuki Sato et al. · Scientific Reports · 2017 · 85 citations · Full text

Aprepitant for refractory nivolumab-induced pruritus

Jiro Ito, Daichi Fujimoto, Ayaka Nakamura et al. · Lung Cancer · 2017 · 63 citations

Medicine, Pharmacotherapy, Refractory Nivolumab-induced Pruritus +1

The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman’s disease

Ikuko Kubokawa, Akihiro Yachie, Akira Hayakawa et al. · BMC Pediatrics · 2014 · 57 citations · Full text

Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non–Small Cell Lung Cancer

Daichi Fujimoto, Yuki Sato, Keiichiro Uehara et al. · Journal of Thoracic Oncology · 2017 · 57 citations

Medicine, Immunology, Tumor Immunity +8